Boehm G, Fanaro S, Jelinek J, Stahl B, Marini A
Numico Research, Friedrichsdorf, Germany.
Acta Paediatr Suppl. 2003 Sep;91(441):64-7. doi: 10.1111/j.1651-2227.2003.tb00648.x.
In the neonatal period, the intestine is colonised in a stepwise process that depends on mode of delivery, environmental factors, bacterial interactions, and the host itself resulting in a colonisation with a complex heterogeneous bacterial flora. Oligosaccharides have been identified as an important prebiotic factor of human milk As long as analogues of human milk oligosaccharides are not available now and in the near future it is aimed to resemble the prebiotic effect of human milk by oligosaccharides from available sources. In the present study in preterm infants, a mixture of 90% galacto-oligosaccharides and 10% fructo-oligosaccharides has been tested. The mixture of GOS/FOS was composed to mimic the molecule size distribution of human milk oligosaccharides. Microbiological analysis of the faces was performed before and 7, 14, and 28 days after start of supplementation and stool characteristics have been recorded. Maltodextrin was used as placebo and infants fed human milk have been used as reference. After a 28 days feeding period, the number of bifidobacteria of the group fed the oligosaccharide supplemented formula was in the upper range of the reference group whereas the numbers of the group fed the formula supplemented with the placebo were in the lower range of the reference group (placebo: 7.9 +/- 0.83 and GOS/FOS mixture: 10,0 +/- 2.05 log 10 CFU/g wet stool; reference (M +/- SD): 7.14-10.7 log 10 CFU/g wet stool). Stool characteristics in the group fed the supplemented formula were close to those found in the human milk fed infants. In summary, supplementation of a preterm formula with a mixture of galacto- and fructo-oligosaccharides has a stimulating effect on the growth of bifidobacteria in the intestine and results in more frequent produced and softer stools. Thus, prebiotic mixtures such like the studied oligosaccharide mixture might help in improving intestinal tolerance to enteral feeding in preterm infants.
在新生儿期,肠道的定植是一个逐步进行的过程,这一过程取决于分娩方式、环境因素、细菌相互作用以及宿主自身,最终导致复杂的异质细菌菌群定植。低聚糖已被确定为人乳中的一种重要益生元因子。由于目前及在可预见的将来都无法获得人乳低聚糖类似物,因此旨在通过使用现有来源的低聚糖来模拟人乳的益生元效应。在本项针对早产儿的研究中,测试了由90%的低聚半乳糖和10%的低聚果糖组成的混合物。低聚半乳糖/低聚果糖混合物的组成旨在模拟人乳低聚糖的分子大小分布。在补充剂开始前以及开始补充后7天、14天和28天对粪便进行微生物学分析,并记录粪便特征。使用麦芽糊精作为安慰剂,以喂养人乳的婴儿作为对照。经过28天的喂养期后,喂食添加低聚糖配方奶组的双歧杆菌数量处于对照组的较高范围,而喂食添加安慰剂配方奶组的双歧杆菌数量处于对照组的较低范围(安慰剂组:7.9±0.83,低聚半乳糖/低聚果糖混合物组:10.0±2.05 log10 CFU/g湿粪便;对照组(均值±标准差):7.14 - 10.7 log10 CFU/g湿粪便)。喂食添加配方奶组的粪便特征与喂食人乳婴儿的粪便特征相近。总之,在早产儿配方奶中添加低聚半乳糖和低聚果糖混合物对肠道中双歧杆菌的生长具有刺激作用,并导致排便更频繁且粪便更软。因此,像所研究的低聚糖混合物这样的益生元混合物可能有助于提高早产儿对肠内喂养的肠道耐受性。